Yayın:
Novel asymmetric biscarbothioamides as Alzheimer's disease associated cholinesterase inhibitors: synthesis, biological activity, and molecular docking studies

Basit Görünüm
dc.contributor.authorMuğlu, Halit
dc.contributor.authorYakan, Hasan
dc.contributor.authorErdoğan, Musa
dc.contributor.authorTopal, Fevzi
dc.contributor.authorTopal, Meryem
dc.contributor.authorTürkeş, Cüneyt
dc.contributor.authorBeydemir, Şükrü
dc.date.accessioned2026-01-04T19:52:45Z
dc.date.issued2024-01-01
dc.description.abstractInvestigating innovative frameworks for addressing Alzheimer's disease is a challenging goal. In this specific scenario, a selection of asymmetric biscarbothioamide derivatives (3a–l) with different substitutions has been carefully formulated and successfully synthesized.
dc.description.urihttps://doi.org/10.1039/d4nj01462f
dc.description.urihttps://hdl.handle.net/11552/7936
dc.identifier.doi10.1039/d4nj01462f
dc.identifier.eissn1369-9261
dc.identifier.endpage10989
dc.identifier.issn1144-0546
dc.identifier.openairedoi_dedup___::cf42fd4444c7333d1b51ce653c23a712
dc.identifier.orcid0000-0002-4428-4696
dc.identifier.orcid0000-0001-6097-2862
dc.identifier.orcid0000-0002-2443-2372
dc.identifier.orcid0000-0002-2107-8603
dc.identifier.scopus2-s2.0-85195081063
dc.identifier.startpage10979
dc.identifier.urihttps://hdl.handle.net/20.500.12597/41429
dc.identifier.volume48
dc.identifier.wos001237448100001
dc.language.isoeng
dc.publisherRoyal Society of Chemistry (RSC)
dc.relation.ispartofNew Journal of Chemistry
dc.rightsCLOSED
dc.subjectAnticancer Activity
dc.subjectThiourea
dc.subjectAntioxidant Activity
dc.subjectDerivatives
dc.subject.sdg3. Good health
dc.titleNovel asymmetric biscarbothioamides as Alzheimer's disease associated cholinesterase inhibitors: synthesis, biological activity, and molecular docking studies
dc.typeArticle
dspace.entity.typePublication
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Koleksiyonlar

Publications